Your privacy choices

Essential storage keeps the site working. With your permission, we also measure visits and interactions on public research pages using first-party analytics. Optional third-party analytics and advertising trackers are currently disabled.

Read our privacy policy
Educational research only—not investment advice or a recommendation. Scores and estimates may use delayed, incomplete, restated, or corrected market and filing data. Independently verify information before making an investment decision.

Jin Medical International Ltd.

ZJYLNASDAQ
Wall Street Score · overall investment55/100
$1.94USD$-0.06 (-3.00%)
Company website www.zhjmedical.com
HeadquartersNo. 33 Lingxiang Road, Changzhou, JS, CN
Financial statement currencyUSD · no FX conversion applied
Healthcare · Medical - Instruments & Supplies
Price updated todayFinancials updated Oct 1, 2026
Price Chart$-0.21 (-9.77%)
2026-09-042026-09-092026-09-112026-09-152026-09-172026-09-212026-09-232026-09-252026-09-292026-10-02$1.87$1.98$2.09$2.20$2.31

Company & revenue

About Jin Medical International Ltd.

Who they are

Jin Medical International Ltd. specializes in the conception, production, and worldwide distribution of mobility and daily living aids, including wheelchairs, for individuals with disabilities or restricted movement. Their product range additionally features oxygen concentrators and specialized bathing devices. Established in 2006, the company is headquartered in Changzhou, China, and operates as a subsidiary of Jolly Harmony Enterprises Limited.

Detailed revenue, brand and relationship research has not yet been completed for ZJYL.

Wall Street Score

Overall investment score · Quality, value, risk and opportunity

55

Fair

PoorElite

View category scores →

Company Quality

How good is the actual business—regardless of today’s stock price?

53

Fair

Financial Strength

37

Business Quality / Moat

62

Management

71

Growth Quality

40

Risk / Durability

60

Cheap for a Reason · Review the Risks

Uses financial strength, moat, management, growth quality and durability. It excludes share price, P/E, market cap, intrinsic value and margin of safety.

Opportunity

Opportunity Score · How does the current price compare with estimated value?

69

Fully Valued

Based on current valuation, company quality, recent trends, and available market signals.

View score details →

Model Outlook

12-month model · What does the model think happens next?

62/100

Building Historical Record

Model Score 62/100 — estimates relative performance potential, distinct from WallStreetScore (company quality).

Probability unavailable — the model has not produced a calibrated probability yet.

Click for full breakdown →

WSS View

The quick read

WSS currently rates the company as mixed to moderately strong.

At today’s price, the WSS valuation framework currently reads as moderate rather than unusually attractive.

The model outlook is currently moderate.

What we like
  • •Asset quality scores strongly
  • •Valuation scores attractively
What to watch
  • •Debt service risk
  • •Debt / balance-sheet profile needs attention

Company-specific research

Questions worth answering for ZJYL

Research inputs 100% complete

These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.

  • •Can ZJYL maintain its current revenue growth rate and improve the amount of that revenue that turns into earnings and cash?
  • •How long can ZJYL fund negative free cash flow using its current cash position before it may need more debt or new shares?
  • •Is ZJYL's debt load manageable relative to cash generation, interest costs and upcoming maturities?
  • •Is ZJYL's valuation discount tied to a temporary concern or to a longer-term business risk?
  • •What does the current fundamental change risk warning mean for the reliability or interpretation of ZJYL's score?
Debt service risk
Business analysis: 38 days ago · Fresh

Essential Investment Snapshot

Wall Street Score

55

0–100 · Fair

Opportunity Score

69

0–100 · Fair

Market Cap

$15.2M

P/E Ratio

5.3

EPS

$0.37

52-Week High

$12.00

52-Week Low

$1.53

Beta

7.33

Intrinsic Value

$5.08

Shares Outstanding

7.8M

Total Revenue

$42.6M

Total Debt

$20.6M

Dividend

No current dividend

View dividend history

Liquidation Value / Share

$3.85

Estimated net asset value per share

Momentum & Volatility Signals

Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.

0–100 market signals
Momentum
36/ 100
+19 pts / 5d

Weakening momentum

5D +1.6% · 20D -9.8% · RSI 48 · Price vs 20D avg -3.4%
Volatility
55/ 100
+1 pts / 5d

Elevated movement

20D realized vol 66.3% · 60D 114.5% · Acceleration 0.58x
Momentum = Where is it going?

A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.

Volatility = How violently is it moving?

A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.

Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.

Notices for ZJYL

Detected from reported data — verify before acting.

Debt service risk

Interest coverage is low (~1.5x). Earnings may be strained to cover interest expense.

Community Sentiment

0 active · 0 total calls
0% Bullish (0) 0% Bearish (0)

No personal call yet on ZJYL.

What the Bulls Say

  • +Growth opportunities may come from revenue expansion, margin improvement, new products, market-share gains, and stronger cash flow.
  • +Product opportunity: Jin Medical International Ltd. specializes in the conception, production, and worldwide distribution of mobility and daily living aids, including wheelchairs, for individuals with disabilities or restricted movement. Their product range additionally features oxygen concentrators and specialized bathing devices. Established in 2006, the company is headquartered in Changzhou, China, and operates as a subsidiary of Jolly Harmony Enterprises Limited.

What the Bears Say

  • −Key risks may include competition, margin pressure, debt levels, valuation risk, and changes in demand within the Medical - Instruments & Supplies industry.
  • −Negative free cash flow may increase the need for outside financing and dilution.

Bull and bear cases summarize disclosed catalysts, growth opportunities and risks; they are not buy or sell recommendations.

Create a free account to make a call.

Scores

Click any score for full breakdown
Wall Street Score
Fair55/ 100
Weak (0–50)Fair (51–71)Strong (72+)

Fair

55

Tap for breakdown →

Poor

37

Debt Cost2.2%
Debt Reduction YoY-63.0%
Debt / Equity0.64x

Tap for breakdown →

Fair

60

Revenue YoY1.1%
Revenue CAGR2.2%
Net Margin7.0%

Tap for breakdown →

Strong

89

Asset Growth YoY16.5%
Liquidation/Share$3.85
Net Assets/MCap2.27x

Tap for breakdown →

Fair

67

Earnings Yield19.1%
Buyback Yield0.0%
Debt Cost2.2%

Tap for breakdown →

Strong

71

ROIC1.3%
ROE9.8%
ROA5.3%

Tap for breakdown →

Fair

62

EPS Growth-23.1%
FCF/Share Growth—
Rev/Share Growth6.6%

Tap for breakdown →

Elite

100

Intrinsic Value$5.08
Value Reference$3.05
MOS0.6%

Tap for breakdown →

Fair

64

Revenue60
Moat62
Valuation100

Tap for breakdown →

Elite

100

MOS %0.6%
Value Reference$3.05
Deep Discount Reference$2.03

Tap for breakdown →

Fair

52

Interest Coverage1.5x
ROIC1.3%
FCF Yield-24.0%

Tap for breakdown →

Strong

76

Financial52
Valuation100
Debt37

Tap for breakdown →

Fair

60

Survival Years8.0 yrs
Current Ratio1.86x
FCF Margin-0.2%

Tap for breakdown →

Was this stock page easy to understand?

One click helps us improve the research experience. This is not tied to an investment decision.

Score Changes

2 historical score records available

Previous Score

50

Jul 24, 2026

Change

+5.2

points

Current Score

55

Oct 1, 2026

Category Changes

Revenue-1.6
Debt0
Assets0
Capital0
Management-6.9
Moat0
Valuation+77.5
Buffett+6.4

ZJYL increased 5.2 points because Valuation improved by 77.5 points, Buffett improved by 6.4 points.

Positive Contributors

  • + Valuation improved by 77.5 points
  • + Buffett improved by 6.4 points

Negative Contributors

  • − Management declined by 6.9 points

Projected Score

Projected Score

51

Projected Change

-4.2%

Preliminary comparable-period financial changes suggest decline of approximately 4.2 points. This is a projected estimate, not the official WallStreetScore.

Price vs. Value

Undervalued

Current Price

$1.94

Intrinsic Value

$5.08

Difference

−$3.14

-61.8% vs IV

Margin of Safety

61.8%

UndervaluedFair ValueOvervalued
Value Reference: $3.05
Deep Discount Reference: $2.03

Related Companies

Medical - Instruments & Supplies

NEPH

Nephros, Inc.

64Fair
$3.67View

PDEX

Pro-Dex, Inc.

63Fair
$64.07View

RMD

ResMed Inc.

59Fair
$218.89View

LMAT

LeMaitre Vascular, Inc.

58Fair
$80.19View

NNNN

Anbio Biotechnology Class A Ordinary Shares

49Weak
$5.55View

DXR

Daxor Corporation

49Weak
$10.62View

News

Defense World52d ago

Jin Medical International Ltd. (NASDAQ:ZJYL) Sees Significant Decrease in Short Interest

PRNewsWire59d ago

JIN MEDICAL INTERNATIONAL LTD. Reports First Half of Fiscal Year 2026 Financial Results

Related Stock Research

Continue researching this company with related Wall Street Score rankings and investing guides.

Highest Wall Street Score stocksStocks under $10Best value stocksBest growth stocksBest healthcare stocksHow Wall Street Score worksHow to analyze a stock

Score Alerts

Premium unlocks alerts when a score rises, falls, or reaches your target price.

Start 7-Day Free Trial

Portfolio Score

Premium unlocks portfolio scoring, strongest and weakest holdings, and overall margin of safety.

Start 7-Day Free Trial